Table 3. Percentage of Participants Meeting Metabolic syndrome Criteria as Reported by Particular Treatment.

Table 3 outlines under each column heading, the number (and percentage) of participants receiving the various treatments as listed in column 1. Five columns are represented in this table. The first column lists the various treatment measures investigated in the study. The second, third and fourth columns list the number of participants receiving each respective treatment that 1) don’t meet criteria for metabolic syndrome, do meet criteria for metabolic syndrome, and 3) are receiving the particular treatment. The fifth column lists the percentage of participants receiving the particular treatment who meet criteria for metabolic syndrome. This is calculated by a ratio of column three/column four.

Psychopharmacological Treatment	No Metabolic syndrome (N=73)	Metabolic syndrome (N=26)	Total Study Subjects (N=99)	% of Subjects who Meet Metabolic syndrome Criteria
AAP	30	16	46	35 %
Olanzepine	2	4	6	67 %
Quetiapine	19	8	27	30 %
Risperidone	5	3	8	38 %
Paliperidone	2	2	4	50 %
Clozapine	3	0	3	0 %
Monotherapy (i.e. one medication)	37	11	48	23 %
Antipsychotics and Mood Stabilizers	32	13	45	29 %
Mood Stabilizer	54	17	71	24 %